Latest reported quarter: Q4, ended Dec 2024 · reported in GBP
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (GBP) |
2025 ANNUAL (GBP) |
2025 Q4 (GBP) |
2025 Q2 (GBP) |
2024 ANNUAL (GBP) |
|---|---|---|---|---|---|
| Total Assets | £32.58B | £32.63B | £32.63B | £31.83B | £34.32B |
| Total Current Assets | £4.29B | £4.55B | £4.55B | £4.14B | £5.72B |
| Cash and Cash Equivalents & Short-Term Investments | £826.00M | £1.26B | £1.26B | £676.00M | £2.20B |
| -Cash and Cash Equivalents | £826.00M | £1.26B | £1.26B | £676.00M | £2.20B |
| -Accounts Receivable | £2.29B | £1.64B | £1.64B | £2.14B | £1.59B |
| -Taxes Receivable | £59.00M | £194.00M | £194.00M | £63.00M | £244.00M |
| Inventory | £1.07B | £1.03B | £1.03B | £1.13B | £1.19B |
| Total Non-Current Assets | £28.29B | £28.08B | £28.08B | £27.68B | £28.60B |
| Net PPE | £2.06B | £2.00B | £2.00B | £1.87B | £1.92B |
| -Gross PPE | £2.06B | £3.56B | £3.56B | £1.87B | £3.35B |
| Financial Assets | £8.00M | £9.00M | £9.00M | £18.00M | £0.00 |
| Goodwill and Other Intangible Assets | £25.75B | £25.61B | £25.61B | £25.37B | £26.21B |
| Defined Pension Benefit | £82.00M | £68.00M | £68.00M | £54.00M | £36.00M |
| Other Non-Current Assets | £42.00M | £37.00M | £37.00M | £55.00M | £71.00M |
| Total Liabilities | £16.14B | £16.15B | £16.15B | £15.83B | £18.09B |
| Total Current Liabilities | £6.24B | £4.93B | £4.93B | £4.76B | £5.81B |
| Payables | £4.06B | £3.68B | £3.68B | £3.79B | £3.63B |
| -Accounts Payable | £3.80B | £2.06B | £2.06B | £3.56B | £1.97B |
| -Total Tax Payable | £265.00M | £312.00M | £312.00M | £231.00M | £286.00M |
| Short-Term Debt and Capital Lease Obligation | £1.96B | £836.00M | £836.00M | £813.00M | £1.49B |
| -Current Debt | £1.91B | £788.00M | £788.00M | £768.00M | £1.44B |
| -Current Capital Lease Obligation | £52.00M | £48.00M | £48.00M | £45.00M | £50.00M |
| Current Provisions | £188.00M | £69.00M | £69.00M | £105.00M | £118.00M |
| Total Non-Current Liabilities | £9.90B | £11.21B | £11.21B | £11.07B | £12.28B |
| Long Term Debt and Capital Lease Obligation | £6.27B | £7.75B | £7.75B | £7.64B | £8.62B |
| -Long Term Debt | £6.15B | £7.66B | £7.66B | £7.55B | £8.54B |
| -Long Term Capital Lease Obligation | £111.00M | £85.00M | £85.00M | £87.00M | £73.00M |
| Derivative Product Liabilities | £108.00M | £34.00M | £34.00M | £13.00M | £70.00M |
| Non-Current Liabilities | £60.00M | £40.00M | £40.00M | £33.00M | £57.00M |
| Convertible preferred securities | £25.00M | £25.00M | £25.00M | £25.00M | £25.00M |
| Other Non-Current Liabilities | £39.00M | £30.00M | £30.00M | £25.00M | £28.00M |
| Total Equity | £16.44B | £16.48B | £16.48B | £16.00B | £16.22B |
| Stockholders' Equity | £16.38B | £16.43B | £16.43B | £15.94B | £16.17B |
| Capital Stock | £88.00M | £90.00M | £90.00M | £90.00M | £91.00M |
| -Common Stock | £88.00M | £90.00M | £90.00M | £90.00M | £91.00M |
| Retained Earnings | £27.69B | £27.85B | £27.85B | £27.27B | £27.27B |
| Minority Interests | £60.00M | £59.00M | £59.00M | £57.00M | £58.00M |
| -Other Receivables | – | £287.00M | £287.00M | – | £316.00M |
| Restricted Cash | – | £64.00M | £64.00M | – | £55.00M |
| -Accumulated Depreciation | – | -£1.56B | -£1.56B | – | -£1.43B |
| -Goodwill | – | £8.13B | £8.13B | – | £8.20B |
| -Other Intangible Assets | – | £17.49B | £17.49B | – | £18.01B |
| -Other Payable | – | £1.31B | £1.31B | – | £1.37B |
| Additional Paid-In Capital | – | £2.00M | £2.00M | – | £1.00M |
| Less: Treasury Stock | – | £156.00M | £156.00M | – | £116.00M |
| Line item | 2025 ANNUAL (GBP) |
2024 ANNUAL (GBP) |
2024 Q4 (GBP) |
2024 Q3 (GBP) |
2024 Q2 (GBP) |
|---|---|---|---|---|---|
| Total Revenue as Reported | £11.03B | £11.23B | £2.76B | £2.78B | £2.78B |
| Total Operating Revenue | £11.03B | £11.23B | £2.76B | £2.78B | £2.78B |
| Cost of Revenue | £3.95B | £4.41B | £1.23B | £1.03B | £1.07B |
| Gross Profit | £7.08B | £6.82B | £1.53B | £1.75B | £1.71B |
| Operating Expense | £4.67B | £4.62B | £1.18B | £1.04B | £1.21B |
| Selling and Admin Expenses | £4.36B | £4.45B | £1.11B | £1.09B | £1.15B |
| -General & Admin Expense | £4.36B | £4.45B | £1.11B | £1.09B | £1.15B |
| Research & Development | £316.00M | £298.00M | £78.00M | £76.00M | £73.00M |
| Other Operating Expenses | -£12.00M | -£132.00M | -£6.00M | -£124.00M | -£9.00M |
| Operating Profit | £2.41B | £2.21B | £350.00M | £705.00M | £496.00M |
| Net Non-Operating Interest Income (Expense) | -£305.00M | -£339.00M | -£99.00M | -£78.00M | -£87.00M |
| Non-Operating Interest Income | £57.00M | £65.00M | £22.00M | £12.00M | £9.00M |
| Non-Operating Interest Expense | £347.00M | £394.00M | £111.00M | £90.00M | £96.00M |
| Total Other Finance Costs | £15.00M | £10.00M | – | – | – |
| Special Income (Charges) | £52.00M | -£7.00M | -£13.00M | -£1.00M | -£3.00M |
| -Less:Other Special Charges | -£52.00M | £7.00M | £13.00M | £1.00M | £3.00M |
| Pretax Profit | £2.15B | £1.91B | £288.00M | £626.00M | £406.00M |
| Tax | £472.00M | £435.00M | £66.00M | £127.00M | £93.00M |
| Net Profit | £1.68B | £1.48B | £222.00M | £499.00M | £313.00M |
| Profit from Continuing Operations | £1.68B | £1.48B | £222.00M | £499.00M | £313.00M |
| Minority Interests | £13.00M | £33.00M | -£9.00M | £14.00M | £10.00M |
| Net Income to Parent Company | £1.67B | £1.44B | £231.00M | £485.00M | £303.00M |
| Other Preferred Stock Dividends | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| Net Income to Common Stockholders | £1.67B | £1.44B | £231.00M | £485.00M | £303.00M |
| Basic EPS | £0.37 | £0.32 | £0.05 | £0.11 | £0.07 |
| Diluted EPS | £0.37 | £0.31 | £0.05 | £0.11 | £0.07 |
| Dividend Per Share | £0.14 | £0.12 | £0.00 | £0.04 | £0.00 |
| Line item | 2025 ANNUAL (GBP) |
2024 ANNUAL (GBP) |
2023 ANNUAL (GBP) |
2022 ANNUAL (GBP) |
2021 ANNUAL (GBP) |
|---|---|---|---|---|---|
| Operating Cash Flow | £2.63B | £2.30B | £2.10B | £2.06B | £1.36B |
| Net Income from Continuing Operations | £1.68B | £1.48B | £1.11B | £1.12B | £1.44B |
| Deferred Tax | £472.00M | £435.00M | £517.00M | £499.00M | £197.00M |
| Other Non-Cash Items | £288.00M | £287.00M | £357.00M | £216.00M | -£20.00M |
| Change in Working Capital | £256.00M | £206.00M | -£107.00M | £181.00M | -£152.00M |
| -Change in Receivables | -£65.00M | -£312.00M | £38.00M | -£85.00M | £14.00M |
| -Change in Inventory | £133.00M | £216.00M | -£131.00M | -£292.00M | -£17.00M |
| -Change in Other Current Assets | £63.00M | £144.00M | -£126.00M | £171.00M | -£190.00M |
| Net cash flow from investing | -£346.00M | £528.00M | -£134.00M | -£8.78B | -£33.00M |
| Net PPE Purchase and Sale | -£322.00M | -£250.00M | -£234.00M | -£304.00M | -£216.00M |
| Net Intangibles Purchase and Sale | -£91.00M | £257.00M | £144.00M | £12.00M | £67.00M |
| Net Business Purchase and Sale | £13.00M | £446.00M | -£71.00M | £0.00 | £0.00 |
| Net Investment Purchase and Sale | -£6.00M | £0.00 | £0.00 | £700.00M | £100.00M |
| Financing Cash Flow | -£3.14B | -£1.54B | -£1.57B | £6.91B | -£1.24B |
| Net Issuance Payments Of Debt | -£1.31B | £652.00M | -£553.00M | £9.49B | £8.00M |
| Net Common Stock Issuance | -£654.00M | -£619.00M | £0.00 | £0.00 | – |
| Cash Dividends Paid | -£612.00M | -£570.00M | -£388.00M | -£2.68B | -£1.15B |
| Net Other Financing Charges | -£143.00M | -£501.00M | -£110.00M | £363.00M | -£8.00M |
| Ending Cash Balance | £1.30B | £2.21B | £994.00M | £611.00M | £406.00M |
| Net Change in Cash | -£855.00M | £1.29B | £398.00M | £190.00M | £87.00M |
| Beginning Cash Balance | £2.21B | £994.00M | £611.00M | £406.00M | £323.00M |
| Effect of Exchange Rate Changes | -£49.00M | -£79.00M | -£15.00M | £15.00M | -£4.00M |
| Free Cash Flow | £2.22B | £1.98B | £1.76B | £1.74B | £1.06B |
No comments yet — be the first to weigh in on HLN.